RPL21P11

Across TCGA pan-cancer cohorts, RPL21P11 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated RPL21P11 data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher RPL21P11 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPL21P11 expression acts as an unfavorable survival marker, although some lineages such as LGG and SKCM show a favorable association.

OV, LIHC, and ACC are the cancer types where RPL21P11 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Median	All	0.272	0.369	.002	68	view →
LIHC	OS	Quartile	II,III,IV	0.565	0.886	.001	62	view →
ACC	DFS	Quartile	II,III,IV	0.258	0.702	.001	51	view →
COAD	DFS	Median	II,III,IV	0.565	0.729	.006	33	view →
LGG	OS	Quartile	All	0.939	0.810	<.001	28	view →
HNSC	OS	Tertile	All	0.719	0.814	.006	27	view →
SKCM	OS	Quartile	III,IV	0.511	0.251	.002	26	view →
UVM	OS	Median	III,IV	0.382	0.796	.015	21	view →
THCA	DFS	Quartile	All	0.925	0.770	.012	15	view →
LUAD	OS	Quartile	II,III,IV	0.450	0.767	.006	14	view →
KIRC	OS	Median	All	0.714	0.557	.001	13	view →
DLBC	DFS	Tertile	All	0.896	0.595	.025	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

RPL21P11–OV (OS)

Open the OV breakdown →